anti rage (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
94
Structured Review
R&D Systems
anti rage
Anti Rage, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+rage+fc+chimera+protein/Recombinant+Human+RAGE+Fc+Chimera+Protein%2C+CF/pmc12992257-37-16-17
Average 94 stars, based on 20 article reviews
Anti Rage, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+rage+fc+chimera+protein/Recombinant+Human+RAGE+Fc+Chimera+Protein%2C+CF/pmc12992257-37-16-17
Average 94 stars, based on 20 article reviews
anti rage - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Recombinant:Article Title: Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein Article Snippet: In control experiments, FITC-labelled Dextran (mol wt 500KD, lysine fixable, from Life Technologies), fluorescent latex beads (30 nm, Sigma, L5155) and Alexa Flour 596-labelled Cholera toxin B (Life Technologies) were used as specific ligands for different endocytic mechanisms. .. Anti-mouse LOX1 (AF1564, RD systems), anti-human RAGE (MAB11451, RD systems) and Article Title: Selective Anticancer Effects by Oxyclozanide in Triple-Negative Breast Cancer Expressing S100A9 Article Snippet: S100A9 binds to the receptor for advanced glycation end products (RAGE), forming a complex that activates various signaling pathways in cancer cells.. Accordingly, inhibitors of this interaction are potential therapeutic targets.. We identified and characterized oxyclozanide, a small molecule that has selective anti-cancer effects in vitro and in vivo through the inhibition of interactions between S100A9 and RAGE in triple-negative breast cancer (TNBC) cells expressing S100A9. Article Title: Geniposide ameliorates diabetic nephropathy in type 2 diabetic mice by targeting AGEs-RAGE-dependent inflammatory pathway. Article Snippet: Background: Diabetic nephropathy (DN) is a prevalent complication of diabetes mellitus and the primary cause of morbidity and mortality in end-stage renal disease.. The receptor for advanced glycation end products (RAGE) plays a crucial role in mediating AGE-triggered inflammation, which has been implicated in DN pathogenesis.. While geniposide, a natural compound, has demonstrated anti-inflammatory and hypoglycemic properties, its potential to mitigate AGE-induced renal inflammation and consequently impede DN progression remains Incubation:Article Title: Geniposide ameliorates diabetic nephropathy in type 2 diabetic mice by targeting AGEs-RAGE-dependent inflammatory pathway. Article Snippet: Background: Diabetic nephropathy (DN) is a prevalent complication of diabetes mellitus and the primary cause of morbidity and mortality in end-stage renal disease.. The receptor for advanced glycation end products (RAGE) plays a crucial role in mediating AGE-triggered inflammation, which has been implicated in DN pathogenesis.. While geniposide, a natural compound, has demonstrated anti-inflammatory and hypoglycemic properties, its potential to mitigate AGE-induced renal inflammation and consequently impede DN progression remains |